This inventor holds 1 USPTO granted patent and 13 published patent applications and 3 EPO patents. Top assignee: Academy of Military Medical Sciences. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Zhihong Hu: Innovator in Coronavirus Treatment
Introduction
Zhihong Hu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has garnered attention for its potential impact on public health.
Latest Patents
Zhihong Hu holds a patent for the use of Favipiravir in the treatment of coronavirus infection. The patent details a Favipiravir compound represented by Formula I, including a geometric isomer, a pharmaceutically acceptable salt, a solvate, and/or a hydrate thereof. The pharmaceutical composition comprising this compound is aimed at treating coronavirus infections.
Career Highlights
Zhihong Hu is affiliated with the Academy of Military Medical Sciences, where he conducts research and development in medical science. His work focuses on innovative solutions to combat viral infections, showcasing his dedication to advancing healthcare.
Collaborations
Zhihong Hu has collaborated with notable colleagues, including Wu Zhong and Ruiyuan Cao. These partnerships enhance the research efforts and contribute to the development of effective treatments.
Conclusion
Zhihong Hu's contributions to the field of medicine, particularly through his patent on Favipiravir, highlight his role as an innovator in the fight against coronavirus infections. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile